InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,222.68
(
0.16%
)
US TECH 100
17,652.00
(
0.06%
)
Dow Jones
39,512.84
(
0.32%
)
Brent Oil
82.59
(
0.00%
)
Bitcoin
60,732.66
(
-0.10%
)
Post# of 30046
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Old Git

Send PM Follow Ignore
Followers 6
Posts 191
Boards Moderated 0
Alias Born 11/06/2010

Old Git

Re: None

Friday, 10/24/2014 12:10:06 PM

Friday, October 24, 2014 12:10:06 PM

Post# of 30046
Vectorite Biomedica inc






24-02-2006: AMDL, Inc. announced that it has signed a Memorandum of Understanding (MOU) with Vectorite Biomedica, Inc., a Taiwan based company, that could lead to the development of human and animal clinical trials in Taiwan of AMDL's Combination Immunogene Therapy (CIT), a therapeutic vaccine.

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up